Gentaur Monalizumab – Anti-KLRC1 / NKG2A / CD159a Antibody

Gentaur Monalizumab – Anti-KLRC1 / NKG2A / CD159a Antibody

Recognizes inhibitory receptors on NK and CD8+ T-cells. Used to study immune evasion mechanisms in cancer and viral infection models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

This combination does not exist.

Add to cart Buy now

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Customer Reviews